Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study
Open Access
- 8 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 223 (7) , 1150-1160
Abstract
Background: There are limited data on individual human immunodeficiency virus (HIV) viral load (VL) trajectories at the population-level after the introduction of universal test and treat (UTT) in sub-Saharan Africa. Methods: Human immunodeficiency virus VLs were assessed among HIV-positive participants through 3 population-based surveys in 4 Ugandan fishing communities surveyed between November 2011 and August 2017. The unit of analysis was a visit-pair (2 consecutive person-visits), which were categorized as exhibiting durable VL suppression, new/renewed VL suppression, viral rebound, or persistent viremia. Adjusted relative risks (adjRRs) and 95% confidence intervals (CIs) of persistent viremia were estimated using multivariate Poisson regression. Results: There were 1346 HIV-positive participants (n = 1883 visit-pairs). The population-level prevalence of durable VL suppression increased from 29.7% to 67.9% during UTT rollout, viral rebound declined from 4.4% to 2.7%, and persistent viremia declined from 20.8% to 13.3%. Younger age (15–29 vs 40–49 years; adjRR = 1.80; 95% CI = 1.19–2.71), male sex (adjRR = 2.09, 95% CI = 1.47–2.95), never being married (vs currently married; adjRR = 1.88, 95% CI = 1.34–2.62), and recent migration to the community (vs long-term resident; adjRR = 1.91, 95% CI = 1.34–2.73) were factors associated with persistent viremia. Conclusions: Despite increases in durable VL suppression during roll out of UTT in hyperendemic communities, a substantial fraction of the population, whose risk profile tended to be younger, male, and mobile, remained persistently viremic.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (U01AI100031, U01AI075115, R01AI110324, R01AI128779, R01AI123002, R01AI143333, K01AI125086, T32AI102623)
- National Institute of Mental Health (R01MH107275, R01MH105313)
- National Center for Child Health and Human Development (R01HD091003)
- Division of Intramural Research of the National Institute for Allergy and Infectious Diseases
- Johns Hopkins University Center for AIDS Research (P30AI094189)
- President’s Emergency Plan for AIDS Relief
- Centers for Disease Control and Prevention (NU2GGH000817)
This publication has 33 references indexed in Scilit:
- HIV estimates through 2018AIDS, 2019
- Universal Testing, Expanded Treatment, and Incidence of HIV Infection in BotswanaNew England Journal of Medicine, 2019
- HIV Testing and Treatment with the Use of a Community Health Approach in Rural AfricaNew England Journal of Medicine, 2019
- Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)New England Journal of Medicine, 2019
- Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017Nature, 2019
- HIV Population Surveys — Bringing Precision to the Global ResponseNew England Journal of Medicine, 2018
- HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy—Results From the IeDEA CollaborationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2017
- Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012–2013Clinical Infectious Diseases, 2016
- Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic reviewThe Lancet Infectious Diseases, 2010
- Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet, 2009